Restricted accessResearch articleFirst published online 2024-2
Relationship Between Atherogenic Index of Plasma and Serum Uric Acid in Patients With Untreated Essential Hypertension in China: A Cross-Sectional Study
Several studies have reported that the atherogenic index of plasma (AIP) is associated with serum uric acid (SUA) in healthy middle-aged men, kidney transplant patients, and diabetic patients. We assessed the relationship between AIP and SUA in patients with untreated essential hypertension (EH) in China. In the cross-sectional study, we evaluated 5003 patients with untreated EH in China; 1490 were assigned to the hyperuricemia (HUA) group and 3513 to the normouricemia (non-HUA) group according to the diagnostic criteria of HUA (SUA level≥6 mg/dL in females and ≥7 mg/dL in males). A higher AIP level was found in the HUA group (P < .001), and AIP was positively and independently correlated with SUA after adjusting for statistically significant variables (β = .204, P < .001). Moreover, multivariate logistic regression analysis showed that the AIP was closely and independently related to HUA after adjusting for confounders (odds ratio [OR]: 11.980, 95% confidence interval [CI]: 3.186–45.047, P < .001). Our findings suggested that the AIP was positively and independently associated with SUA, and elevated AIP might be a significant risk factor for HUA in patients with untreated EH in China.
LibbyPBuringJEBadimonL, et al.Atherosclerosis. Nat Rev Dis Prim. 2019;5:56.
2.
DobiasovaM. AIP-atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr Lek. 2006;52:64-71.
3.
IvanovaEAMyasoedovaVAMelnichenkoAAGrechkoAVOrekhovAN. Small dense low-density lipoprotein as biomarker for atherosclerotic diseases. Oxid Med Cell Longev. 2017;2017:1273042.
4.
BaruaLFaruqueMBanikPCAliL. Atherogenic index of plasma and its association with cardiovascular disease risk factors among postmenopausal rural women of Bangladesh. Indian Heart J. 2019;71:155-160.
5.
DobiásováMFrohlichJ. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER (HDL)). Clin Biochem. 2001;34:583-588.
6.
QinZZhouKLiY, et al.The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19:23.
7.
NamJSKimMKParkK, et al.The plasma atherogenic index is an independent predictor of arterial stiffness in healthy Koreans. Angiology. 2022;73:514-519.
8.
LiYWKaoTWChangPKChenW-LWuL-W. Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study. Sci Rep. 2021;11:9900.
9.
CaiGShiGXueSLuW. The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population. Medicine (Baltim). 2017;96:e8058.
10.
NiroumandSKhajedalueeMKhadem-RezaiyanM, et al.Atherogenic Index of Plasma (AIP): a marker of cardiovascular disease. Med J Islam Repub Iran. 2015;29:240.
11.
JayachandranMQuS. Harnessing hyperuricemia to atherosclerosis and understanding its mechanistic dependence. Med Res Rev. 2021;41:616-629.
12.
Martínez-QuintanaETugoresARodríguez-GonzálezF. Serum uric acid levels and cardiovascular disease: the Gordian knot. J Thorac Dis. 2016;8:E1462-E1466.
13.
YuWChengJD. Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective. Front Pharmacol. 2020;11:582680.
14.
FeigDI. Serum uric acid and the risk of hypertension and chronic kidney disease. Curr Opin Rheumatol. 2014;26:176-185.
15.
CiceroAFSalviPD’AddatoSRosticciMBorghiCBrisighella Heart Study group. Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella heart study. J Hypertens. 2014;32:57-64.
16.
BaliarsinghSSharmaNMukherjeeR. Serum uric acid: marker for atherosclerosis as it is positively associated with “atherogenic index of plasma”. Arch Physiol Biochem. 2013;119:27-31.
17.
BiyikZGuneyI. Relationship between uric acid, proteinuria, and atherogenic index of plasma in renal transplant patients. Transplant Proc. 2018;50:3376-3380.
18.
AkbasEMTimurogluAOzcicekA, et al.Association of uric acid, atherogenic index of plasma and albuminuria in diabetes mellitus. Int J Clin Exp Med. 2014;7:5737-5743.
19.
LiuJChenLYuanH, et al.Survey on uric acid in Chinese subjects with essential hypertension (SUCCESS): a nationwide cross-sectional study. Ann Transl Med. 2021;9:27.
20.
de OnisMOnyangoAWBorghiESiyamANishidaCSiekmannJ. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85:660-667.
21.
ChobanianAVBakrisGLBlackHR, et al.The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
22.
HaoYLiHCaoY, et al.Uricase and Horseradish Peroxidase Hybrid CaHPO4 Nanoflower Integrated with Transcutaneous Patches for Treatment of Hyperuricemia. J Biomed Nanotechnol. 2019;15:951-965.
23.
WangLChenFChaiXQYujunCZijieL. Atherogenic index of plasma is an independent risk factor for coronary artery disease and a higher SYNTAX Score. Angiology. 2021;72:181-186.
24.
OnatACanGKayaHHergençG. “Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol. 2010;4:89-98.
25.
NarchiHAlBlooshiA. Prediction equations of forced oscillation technique: the insidious role of collinearity. Respir Res. 2018;19:48.
26.
KanbayMGirerdNMachuJL, et al.Impact of Uric Acid on Hypertension Occurrence and Target Organ Damage: Insights From the STANISLAS Cohort With a 20-Year Follow- up. Am J Hypertens. 2020;33:869-878.
27.
HuangXBZhangWQTangWWLiuY. Prevalence and associated factors of hyperuricemia among urban adults aged 35-79 years in southwestern China: a community-based cross-sectional study. Sci Rep. 2020;10:15683.
28.
ShenSLuYDangY, et al.Effect of aerobic exercise on the atherogenic index of plasma in middle-aged Chinese men with various body weights. Int J Cardiol. 2017;230:1-5.
29.
SunHJWuZYNieXWBianJS. Role of endothelial dysfunction in cardiovascular diseases: the link between inflammation and hydrogen sulfide. Front Pharmacol. 2020;10:1568.
30.
Fernández-MacíasJCOchoa-MartínezACVarela-SilvaJAPérez-MaldonadoIN. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50:285-294.
31.
WuJZhouQWeiZWeiJCuiM. Atherogenic index of plasma and coronary artery disease in the adult population: a meta-analysis. Front Cardiovasc Med. 2021;8:817441.
32.
ViscoVPascaleAVVirtuosoN, et al.Serum uric acid and left ventricular mass in essential hypertension. Front Cardiovasc Med. 2020;7:570000.
33.
ChuYZhaoQZhangMBanBTaoH. Association between serum uric acid and triglycerides in Chinese children and adolescents with short stature. Lipids Health Dis. 2021;20:1.
34.
LiLJChenHRenJYWangLLuoY. Effects of micronized fenofibrate on lipid and uric acid metabolism in patients with hyperlipidemia. Beijing Da Xue Xue Bao Yi Xue Ban. 2009;41:541-544.
35.
HuXLiuJLiW, et al.Elevated serum uric acid was associated with pre-inflammatory state and impacted the role of HDL-C on carotid atherosclerosis. Nutr Metabol Cardiovasc Dis. 2022;32:1661-1669.
36.
CulletonBFLarsonMGKannelWBLevyD. Serum uric acid and risk for cardiovascular disease and death: the framingham heart study. Ann Intern Med1999;131:7-13.
37.
ChobanianAVBakrisGLBlackHR, et al.Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-1252.
38.
PearsonTABlairSNDanielsSR, et al.AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388-391.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
